Yunnan Baiyao To Develop Cosmetic Medicine Business
This article was originally published in PharmAsia News
Yunnan Baiyao Group is planning to pursue the cosmetic medical market in China after its toothpaste foray three years ago saw sales surpassing 600 million yuan. The company and Japan's Maleave Cosmetics recently signed a cosmetic technology transfer agreement, paving the way for Yunnan Baiyao to consolidate the daily chemical business into a key growth area. Analysts observe that drug firms have an edge in developing cosmetic medical products. Many pharmaceutical corporations such as Pientzehuang and Shenghuo Pharmaceutical are gearing toward this field to boost profits. Figures show that the sector is expected to grow by 20 percent when total cosmetic sales in China hit 120 billion yuan by 2010. (Click here for more - Chinese language)
You may also be interested in...
Guardant’s CEO anticipates accelerated adoption and reimbursement of its FDA-approved liquid biopsy assay and more biopharma partnerships.
Public Company Edition: The German mRNA-focused company could raise up to $245m based on its proposed price range, but investor interest could drive the offering’s total higher. Also, Perceptive launches another SPAC, Regeneron sells $2bn in debt and Biohaven secures up to $950m.
Agency commissioner appeals to AMA audience to communicate message that FDA review decisions are based on good science.